About
The Institute of Organic Chemistry and Biochemistry of the Czech Academy of Sciences (IOCB Prague) is an internationally recognised research institute delivering high-quality research at the interface of chemistry, biology, and biomedical sciences. IOCB combines scientific excellence with a strong focus on innovation, interdisciplinary collaboration, and societal impact.
IOCB conducts frontier research across organic, medicinal and computational chemistry, biochemistry, and chemical biology, with particular strengths in drug discovery, molecular mechanisms of disease, advanced experimental methodologies, and translational research. The institute has a proven track record in converting scientific results into real-world applications, including globally impactful therapeutics, supported by an active technology transfer and innovation ecosystem.
Aligned with its Mission and Goals 2026–2030, IOCB aims to advance innovative and human-relevant research approaches, foster international collaboration, and contribute to European research priorities in health, sustainability, and technological advancement. The institute actively engages in collaborative research projects, including Horizon Europe, and works closely with academic, clinical, and industrial partners to translate research outcomes into practical solutions.
IOCB provides state-of-the-art research infrastructure, independent research groups, and strong support for interdisciplinary projects, enabling effective participation in large international consortia and contribution to high-impact European initiatives.